Our manuscript integrates acting mechanisms of HIF-1α to provide a comprehensive perspective of the role of HIF-1α in pancreatic cancer, showing theoretical principle for the targeted therapy of pancreatic cancer. The gene discussed is HIF1A; the disease is familial pancreatic carcinoma.